Company news

Surrozen, Inc. news in 2026

Surrozen, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million

October 20, 2026

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

October 2, 2026

Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

September 8, 2026

Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

August 6, 2026

Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update

May 6, 2026

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 22, 2026

Surrozen to Present at Upcoming Healthcare Investor Conference

February 5, 2026

Decks in 2026